TUHH Open Research
Help
  • Log In
    New user? Click here to register.Have you forgotten your password?
  • English
  • Deutsch
  • Communities & Collections
  • Publications
  • Research Data
  • People
  • Institutions
  • Projects
  • Statistics
  1. Home
  2. TUHH
  3. Publications
  4. Continuous coagulation monitoring in human blood samples via magnetic particle spectroscopy
 
Options

Continuous coagulation monitoring in human blood samples via magnetic particle spectroscopy

Citation Link: https://doi.org/10.15480/882.16803
Publikationstyp
Journal Article
Date Issued
2026-02-25
Sprache
English
Author(s)
Buhné, Maria-Josephina  
Ackers, Justin  
Ahlborg, Mandy  
Gräser, Matthias 
Buzug, Thorsten M.  
Luedtke-Buzug, Kerstin
Knopp, Tobias  
Biomedizinische Bildgebung E-5  
Barkhausen, Jörg Johannes  
Stroeder, Jonas  
Wegner, Franz  
Kloeckner, Roman  
Aderhold, Eric  
Frydrychowicz, Alex  
TORE-DOI
10.15480/882.16803
TORE-URI
https://hdl.handle.net/11420/61817
Journal
International journal of nanomedicine  
Volume
21
Article Number
561511
Citation
International Journal of Nanomedicine 21: 561511 (2026)
Publisher DOI
10.2147/IJN.S561511
Scopus ID
2-s2.0-105031007951
Publisher
Dove Medical Press Ltd
Introduction: Magnetic Particle Imaging (MPI) is a radiation-free imaging modality based on the nonlinear magnetic response of iron oxide nanoparticles, providing high sensitivity and real-time, quantitative, background-free imaging. With the clinical approval of Resotran as an MPI-suitable tracer and the development of first human-scale scanners, clinical applications are within reach. Magnetic Particle Spectroscopy (MPS), the non-imaging counterpart of MPI, enables sensitive analytics by exploiting the signal response of magnetic nanoparticles. In this pilot study, we prove the potential of MPS to continuously monitor blood coagulation in real time. Methods: Blood samples from five volunteers were mixed with the commercial magnetic resonance imaging contrast agent Resotran. The dynamics of the particle signal were assessed in a custom-built MPS-system for a duration of 45 minutes under various conditions, including the presence of anticoagulants (EDTA, Heparin, Citrate) and mechanical stress. The signal amplitude of the fifth harmonic of the MPS was analyzed. To exclude potential thermal effects, the temperature inside the MPS was monitored by using a fiber optic thermometer during the measurements. Results: All Resotran-containing blood samples showed a signal decrease over time. Samples with anticoagulants exhibited no relevant signal decrease (EDTA, Citrate) or a smaller decrease (Heparin) compared to samples without anticoagulants. Additionally, mechanical stress induced a signal decay in all samples, further indicating the link between the observed MPS signal decay and blood coagulation. Conclusion: This study shows that continuous monitoring of human blood coagulation via MPS is feasible, making bedside coagulation monitoring in clinical settings a concrete perspective.
Subjects
blood coagulation
magnetic particle imaging
nanomedicine
nanoparticles
DDC Class
610: Medicine, Health
616: Diseases
530: Physics
Lizenz
https://creativecommons.org/licenses/by-nc/4.0/
Publication version
publishedVersion
Loading...
Thumbnail Image
Name

Continuous Coagulation Monitoring in Human Blood Samples via Magnetic Particle Spectroscopy.pdf

Type

Main Article

Size

1.99 MB

Format

Adobe PDF

TUHH
Weiterführende Links
  • Contact
  • Send Feedback
  • Cookie settings
  • Privacy policy
  • Impress
DSpace Software

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science
Design by effective webwork GmbH

  • Deutsche NationalbibliothekDeutsche Nationalbibliothek
  • ORCiD Member OrganizationORCiD Member Organization
  • DataCiteDataCite
  • Re3DataRe3Data
  • OpenDOAROpenDOAR
  • OpenAireOpenAire
  • BASE Bielefeld Academic Search EngineBASE Bielefeld Academic Search Engine
Feedback